Table 1.
Baseline characteristics of all study participants.
| Variable | Control (n = 100) | STEMI (n = 192) | P value |
|---|---|---|---|
| Age, years | 61.65 ± 12.91 | 62.27 ± 12.24 | 0.689 |
| Gender (n, %) | 0.315 | ||
| Male | 64 (64.00%) | 134 (69.79%) | |
| Female | 36 (36.00%) | 58 (30.21%) | |
| Hypertension (n, %) | 0.346 | ||
| No | 66 (66.00%) | 137 (71.35%) | |
| Yes | 34 (34.00%) | 55 (28.65%) | |
| Diabetes mellitus (n, %) | 0.284 | ||
| No | 82 (82.00%) | 147 (76.56%) | |
| Yes | 18 (18.00%) | 45 (23.44%) | |
| Smoke (n, %) | 0.243 | ||
| No | 82 (82.00%) | 146 (76.04%) | |
| Yes | 18 (18.00%) | 46 (23.96%) | |
| BMI, kg/m2 | 23.13 ± 3.64 | 24.61 ± 2.14 | <0.001 |
| WBC, ×109/L | 6.08 ± 1.77 | 11.67 ± 5.09 | <0.001 |
| Hemoglobin, g/L | 104.64 ± 6.59 | 101.28 ± 12.22 | 0.011 |
| hs-CRP, mg/L | 8.51 ± 41.54 | 31.90 ± 23.07 | <0.001 |
| HDL-C, mmol/L | 1.26 ± 0.26 | 1.06 ± 0.25 | <0.001 |
| LDL-C, mmol/L | 2.73 ± 0.75 | 2.77 ± 0.74 | 0.67 |
| Total cholesterol, mmol/L | 4.58 ± 0.90 | 4.31 ± 0.84 | 0.013 |
| Triglyceride, mmol/L | 1.36 ± 0.79 | 1.42 ± 0.63 | 0.479 |
| LDH, U/L | 171.50 ± 39.02 | 695.38 ± 300.29 | <0.001 |
| CK, U/L | 92.41 ± 49.19 | 720.78 ± 199.33 | <0.001 |
| CKMB, ng/mL | 1.97 ± 1.04 | 112.55 ± 55.82 | <0.001 |
| hsTn T, ng/L | 17.22 ± 10.08 | 783.32 ± 462.74 | <0.001 |
| NT-proBNP, pg/mL | 830.86 ± 471.41 | 1801.27 ± 625.33 | <0.001 |
| LP(a), mg/L | 207.65 ± 162.31 | 254.23 ± 160.02 | 0.019 |
Abbreviations: STEMI: ST-Segment elevation myocardial infarction; WBC: white blood cell; hs-CRP: high-sensitivity C-reactive protein; HDL-C: high-density lipoprotein-cholesterol; LDL: low-density lipoprotein-cholesterol; LDH: lactate dehydrogenase; CK: creatine kinase; CKMB: creatine kinase MB; hsTn T: hypersensitive troponin T; NT-proBNP: N-terminal probrain natriuretic peptide; Lp(a): lipoprotein-a.